Ankylosing Spondylitis
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate the Efficacy and Safety of Upadacitinib in Adult Subjects with Ankylosing Spondylitis
Study Information
| Condition |
Ankylosing Spondylitis |
|---|---|
| Phase | III |
Conquest Research needs volunteers for an ankylosing spondylitis trial evaluating a medication designed for the treatment of rheumatoid arthritis. You may qualify if you:
Are at least 18 years of age
Have a clinical diagnosis of ankylosing spondylitis
Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.
What To Expect
PATIENT RESOURCES & FAQ
Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.
